Experience with germ-reduced platelet transfusions in Germany
Part of Blood & lymphatic clinical trials.
This study is looking at how well a special method works that treats platelets to kill germs (pathogens) before they are given to patients. It may be a good fit if you need regular platelet transfusions because your body doesn't make enough platelets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a low platelet count that increases your risk of bleeding, and you need platelet transfusions.
- You do not have an allergy to amotosalen (a substance used to treat platelets).
- You are not allergic to components of human blood plasma.
- You do not have certain blood disorders, such as immune thrombocytopenia, TTP/HUS, or certain inherited platelet problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a platelet transfusion affects blood vessel function in intensive care patients with low platelet counts (thrombocytopenia). It may help doctors understand if transfusions help the tiny blood vessels work better.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
This trial tests a combined approach to platelet transfusion to see if it works better. It may help patients who need platelet transfusions as part of their hospital treatment.
This trial tests a new drug called CM313 to see if it can help people whose platelet transfusions stop working. It is for adults who need platelet transfusions and have developed antibodies against them.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
Hear when a new Platelet Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.